{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:20:43Z","timestamp":1761898843219,"version":"build-2065373602"},"reference-count":18,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.cancergen.2012.05.008","type":"journal-article","created":{"date-parts":[[2012,8,29]],"date-time":"2012-08-29T11:01:42Z","timestamp":1346238102000},"page":"436-441","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["KIT mutation detection in Tunisian patients with newly diagnosed myelogenous leukemia: prevalence and prognostic significance"],"prefix":"10.1016","volume":"205","author":[{"given":"Slah","family":"Ouerhani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanen","family":"Gharbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samia","family":"Menif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ines","family":"Safra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kais","family":"Douzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salem","family":"Abbes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergen.2012.05.008_bib1","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1200\/JCO.2006.06.9500","article-title":"Cancer and Leukemia Group B adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(821): a Cancer and Leukemia Group B","volume":"24","author":"Paschka","year":"2006","journal-title":"Study. J Clin Oncol"},{"key":"10.1016\/j.cancergen.2012.05.008_bib2","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1182\/blood-2005-04-1466","article-title":"KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival","volume":"107","author":"Schnittger","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2012.05.008_bib3","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.leukres.2007.08.019","article-title":"Increased C-kit intensity is a poor prognostic factor for progression-free and overall survival in patients with newly diagnosed AML","volume":"32","author":"Advani","year":"2008","journal-title":"Leuk Res"},{"key":"10.1016\/j.cancergen.2012.05.008_bib4","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/leu.2008.364","article-title":"The stem cell factor-c-KIT pathway must be inhibited to enable apoptosis induced by BCR-ABL inhibitors in chronic myelogenous leukemia cells","volume":"23","author":"Belloc","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2012.05.008_bib5","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1126\/science.279.5350.577","article-title":"Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors","volume":"2","author":"Hirota","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.cancergen.2012.05.008_bib6","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/sj.leu.2402341","article-title":"Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia\u2013potential clinical significance","volume":"16","author":"Inokuchi","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2012.05.008_bib7","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11899-009-0011-8","article-title":"Clinical implications of c-Kit mutations in acute myelogenous leukemia","volume":"4","author":"Malaise","year":"2009","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.cancergen.2012.05.008_bib8","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/sj.leu.2404188","article-title":"Incidence and prognostic impact of c-Kit FLT3 and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML)","volume":"20","author":"Boissel","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2012.05.008_bib9","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/sj.leu.2403870","article-title":"Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia","volume":"19","author":"Goemans","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2012.05.008_bib10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/sj.thj.6200319","article-title":"High incidence of BCR-ABL kinase domain mutations and absence of mutations of the PDGFR and KIT activation loops in CML patients with secondary resistance to imatinib","volume":"5","author":"Al-Ali","year":"2004","journal-title":"Hematol J"},{"key":"10.1016\/j.cancergen.2012.05.008_bib11","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.patbio.2007.12.010","article-title":"Quantitative detection of bcr-abl transcripts in chronic myeloid leukemia","volume":"57","author":"Menif","year":"2009","journal-title":"Pathol Biol"},{"key":"10.1016\/j.cancergen.2012.05.008_bib12","first-page":"86","article-title":"Long term follow up after allogeneic stem cell transplantation for chronic myelogenous leukemia","volume":"22","author":"Reiter","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.cancergen.2012.05.008_bib13","first-page":"247","article-title":"Frequency of BCR-ABL fusion transcripts in Iranian patients with chronic myeloid leukemia","volume":"11","author":"Yaghmaie","year":"2008","journal-title":"Arch Iran Med"},{"key":"10.1016\/j.cancergen.2012.05.008_bib14","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/S0959-8049(00)00128-3","article-title":"The possible influences of B2A2 and B3A2 BCR\/ABL protein structure on thrombopoiesis in chronic myeloid leukemia","volume":"36","author":"Perego","year":"2000","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.cancergen.2012.05.008_bib15","first-page":"191","article-title":"Relationship of the BCR gene breakpoint and the type of BCR\/ABL transcript to clinical course prognostic indexes and survival in patients with chronic myeloid leukemia","volume":"8","author":"Prejzner","year":"2002","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.cancergen.2012.05.008_bib16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11899-009-0011-8","article-title":"Clinical Implications of c-kit Mutations in Acute Myelogenous Leukemia","volume":"4","author":"Malaise","year":"2009","journal-title":"Current Hematologic Malignancy Reports"},{"key":"10.1016\/j.cancergen.2012.05.008_bib17","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1593\/neo.10356","article-title":"Mutations in the c-Kit gene disrupt mitogen-activated protein kinase signaling during tumor development in adenoid cystic carcinoma of the salivary glands","volume":"12","author":"Tetsu","year":"2010","journal-title":"Neoplasia"},{"key":"10.1016\/j.cancergen.2012.05.008_bib18","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1600-0609.2011.01598.x","article-title":"A\u00a0case of mast cell leukaemia with exon 9 KIT mutation and good response to imatinib","volume":"86","author":"Mital","year":"2011","journal-title":"Eur J Haematol"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776212001391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776212001391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:37:28Z","timestamp":1761896248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776212001391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":18,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S2210776212001391"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2012.05.008","relation":{},"ISSN":["2210-7762"],"issn-type":[{"type":"print","value":"2210-7762"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"KIT mutation detection in Tunisian patients with newly diagnosed myelogenous leukemia: prevalence and prognostic significance","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2012.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}